Is REGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for REGN. It does not provide personalized investment advice.

REGN (Regeneron) Stock Analysis - Financials

Regeneron (REGN) is a publicly traded Healthcare sector company. As of October 1, 2026, REGN trades at $756.50 with a market cap of $77.27B and a P/E ratio of 18.10. REGN moved +1.01% today. Year to date, REGN is -2.32%; over the trailing twelve months it is +34.86%. Its 52-week range spans $476.49 to $859.34. Analyst consensus is buy with an average price target of $839.10. Rallies surfaces REGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are REGN's key financials?

REGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. REGN recently traded at $756.50. Market cap is $77.27B. P/E ratio is 18.10. Revenue is $15.53B.

REGN Key Metrics

Key financial metrics for REGN
Metric	Value
Price	$756.50
Market Cap	$77.27B
P/E Ratio	18.10
EPS	$41.94
Dividend Yield	0.94%
52-Week High	$859.34
52-Week Low	$476.49
Volume	598.59K
Avg Volume	0
Revenue (TTM)	$15.53B
Net Income	$4.33B
Gross Margin	0.00%

REGN Analyst Consensus

20 analysts cover REGN: 0 strong buy, 12 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $839.10.

Common questions about REGN

What are REGN's key financials?: REGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. REGN recently traded at $756.50. Market cap is $77.27B. P/E ratio is 18.10. Revenue is $15.53B.
Is REGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for REGN. It does not provide personalized investment advice.